EARNINGS PER SHARE (Tables)

3 Months Ended

Mar. 31, 2022

Schedule of anti dilutive shares

	March 31, 2022		December 31, 2021
Series A convertible preferred stock		500,000,000		500,000,000
Series B convertible preferred stock		5,000,000		5,000,000
Series C convertible preferred stock		10,000		10,000
Total potentially dilutive shares		505,010,000		505,010,000

Schedule of earning per share

	Three Months Ended March 31,
	2022			2021
Loss from continuing operations	$	(447,774	)	$	(286,114	)
Discontinued operations		–			71,583
Net loss	$	(447,774	)	$	(214,531	)
Basic weighted average outstanding shares of common stock		69,529,624			76,340,735
Dilutive effect of options and warrants		–			–
Diluted weighted average common stock and common stock equivalents		69,529,624			76,340,735
Loss per share:
Net loss per share from continuing operations, basic and diluted	$	(0.01	)	$	(0.01	)
Net loss per share from discontinued operations, basic and diluted		–			0.00
Net loss per share, basic and diluted	$	(0.01	)	$	(0.01	)

Treasury Stock [Member]

Schedule of anti dilutive shares

	March 31, 2022		December 31, 2021
Options to purchase shares of common stock		–		–
Series A convertible preferred stock		500,000,000		500,000,000
Series B convertible preferred stock		5,000,000		5,000,000
Series C convertible preferred stock		10,000		10,000
Total potentially dilutive shares		505,010,000		505,010,000